Cargando…
Angiopoietin-Like 3: From Discovery to Therapeutic Gene Editing
Hyperlipidemia is a major causal risk factor for atherosclerosis and coronary heart disease (CHD). Angiopoietin-like 3 (ANGPTL3) has emerged as a promising molecular target to reduce CHD risk due to its regulation of all 3 major lipid traits: low-density lipoprotein cholesterol, high-density lipopro...
Autores principales: | Wang, Xiao, Musunuru, Kiran |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6834959/ https://www.ncbi.nlm.nih.gov/pubmed/31709322 http://dx.doi.org/10.1016/j.jacbts.2019.05.008 |
Ejemplares similares
-
Therapeutic Genome Editing in Cardiovascular Diseases
por: German, David M., et al.
Publicado: (2019) -
Neuropsychiatric genomics in precision medicine: diagnostics, gene discovery, and translation
por: Need, Anna C., et al.
Publicado: (2016) -
From gene-discovery to gene-tailored clinical management: 25 years of research in channelopathies and cardiomyopathies
por: Crotti, Lia, et al.
Publicado: (2023) -
Pharmacogenomic Discovery to Function and Mechanism: Breast Cancer as a Case Study
por: Wang, Liewei, et al.
Publicado: (2017) -
Leveraging big data to transform target selection and drug discovery
por: Chen, B, et al.
Publicado: (2016)